Our Business

Led by a seasoned team of industry veterans, our mission at inReste is clear: to enhance healthcare and transform lives at scale. By specialising in three pivotal domains—biomedical research and development, clinical diagnostics, and patient solutions—we are determined to push the boundaries of possibility in healthcare. With a focus on cutting-edge technologies and a commitment to excellence, we strive to make a meaningful impact in the lives of individuals and communities worldwide.

A subsidiary of inReste

Restalyst

Restalyst is a biomedical R&D company dedicated to saving lives through early cancer detection. Harnessing the power of proprietary protein biomarkers, Restalyst has commercialised three diagnostic tests designed for the early detection of gastric, liver, and nose cancers. From research and development to production, Restalyst offers a fully integrated solution for bringing life-saving diagnostics to market.

A subsidiary of inReste

ResteLab

Nestled in central Singapore, ResteLab operates a world-class clinical diagnostic laboratory spanning over 18,000 square feet with a daily capacity of 50,000 tests. Among the first in Singapore to leverage technology to automate processes from end-to-end, ResteLab offers a comprehensive menu of tests across seven disciplines to meet diverse patient needs. Our commitment to stringent laboratory protocols ensures consistently high-quality, reliable and accurate results.

Patient Solutions

ResteLife

ResteLife is a digital healthcare management platform designed by inReste to transform the way individuals engage with their health. The platform empowers individuals in their health journey with data-driven insights and secure data access for their chosen healthcare providers. It simplifies workflows and enhances patient care for healthcare professionals through comprehensive patient insights. By bridging the gap between patients and providers, ResteLife ushers in a new era of patient-centered care.